Ekso Bionics Holdings Inc (EKSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 4,950 | 3,756 | 4,847 | 4,607 | 4,703 |
| Cost of Goods | 2,313 | 1,805 | 2,478 | 2,151 | 2,449 |
| Gross Profit | 2,637 | 1,951 | 2,369 | 2,456 | 2,254 |
| Operating Expenses | 5,285 | 6,012 | 6,296 | 5,538 | 6,987 |
| Operating Income | -2,335 | -3,256 | -3,449 | -2,931 | -4,284 |
| Interest Expense | 74 | 57 | 65 | 64 | 61 |
| Other Income | -7 | -116 | 300 | -370 | 115 |
| Pre-tax Income | -2,416 | -3,429 | -3,214 | -3,365 | -4,230 |
| Net Income Continuous | -2,416 | -3,429 | -3,214 | -3,365 | -4,230 |
| Net Income | $-2,416 | $-3,429 | $-3,214 | $-3,365 | $-4,230 |
| EPS Basic Total Ops | -1.99 | -3.00 | -3.30 | -3.60 | -4.65 |
| EPS Basic Continuous Ops | -1.99 | -2.95 | -3.25 | -3.58 | -4.65 |
| EPS Diluted Total Ops | -1.99 | -3.00 | -3.30 | -3.60 | -4.65 |
| EPS Diluted Continuous Ops | -1.99 | -2.95 | -3.25 | -3.58 | -4.65 |
| EPS Diluted Before Non-Recurring Items | -1.95 | -3.00 | -3.30 | N/A | N/A |
| EBITDA(a) | $-1,938 | $-2,850 | $-3,017 | $-2,507 | $-3,856 |